Abstract
In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.
Original language | English (US) |
---|---|
Pages (from-to) | 414-417 |
Number of pages | 4 |
Journal | Community Oncology |
Volume | 7 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2010 |
ASJC Scopus subject areas
- Hematology
- Oncology